Cardiology CME/CE Courses | Cardiovascular Education Course

CME – updated

Cardiology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Type 2 Diabetes and Cardiovascular Outcomes: Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists

Type 2 Diabetes and Cardiovascular Outcomes: Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists | myCME

AMA PRA Category 1 Credit(s)TM
Over the last 2 decades, the risk for adverse CV events has remained largely unchanged while the prevalence of T2DM has dramatically increased. While anti-hyperglycemic therapy improves microvascular outcomes, glycemic control has not been shown to reduce the risk of CV events, a long-term macrovascular outcome. Recently, however, two new classes of anti-hyperglycemic agents have demonstrated CV benefit independent of glycemic control in patients with T2DM and CV disease.
A New Look at Intravenous Platelet Inhibitors in the Cath Lab

A New Look at IV Platelet Inhibitors in the CCL

AMA PRA Category 1 Credit(s)TM
The goal of this symposium is to improve the knowledge and practice of evidence-based medicine and management of patients in the cardiovascular cath lab setting, emphasizing the benefits and risks of antithrombotic therapies.
DOACs in Transition: Examining the Challenges and Complexity of Transitions in Care

Examining Challenges and Complexity of Transitions in Care

AMA PRA Category 1 Credit(s)TM
This clinical commentary features leading thrombosis expert, Dr. Alex Spyropoulos, and a multidisciplinary panel, covering these important questions and how clinicians can ensure that they optimally incorporate these recommendations into their health system.
Breakthroughs for Obese Patients with VTE

Breakthroughs for Obese Patients with VTE | myCME

AMA PRA Category 1 Credit(s)TM
What is the latest evidence for VTE prophylaxis and treatment in obese patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention and management. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice and help them optimize anticoagulant therapy and develop treatment plans in their obese patients.
Are PAH-targeted Therapies Beneficial for CTD-PAH?

Are PAH-targeted Therapies Beneficial for CTD-PAH? | myCME

AMA PRA Category 1 Credit(s)TM
In this video-based activity, Dr. Victor Tapson shares the importance of therapy selection for patients with pulmonary arterial hypertension associated with connective tissue disease. Providing real-world insight and key takeaways for application to clinical practice, Dr. Tapson discusses which PAH therapies are beneficial for patients with CTD-PAH and the importance of a multidisciplinary team while managing these patients.
Improving Outcomes in CTD-PAH: Diagnosis, Treatment & Multidisciplinary Care

Improving Outcomes in CTD-PAH: Diagnosis, Treatment & Multidisciplinary Care | myCME

AMA PRA Category 1 Credit(s)TM
In this interview-style eNewsletter, Dr. Dinesh Khanna and Dr. Victor Tapson share ways to improve the recognition and diagnosis of CTD-PAH. Through discussions on the role of screening and a review of current and emerging therapies, our faculty provide context to creating a personalized treatment approach that highlights the importance of increasing communication across a multidisciplinary team.
Optimizing Medical Management Post-Revascularization – A Case Review

Optimizing Medical Management Post-Revascularization – A Case Review | myCME

AMA PRA Category 1 Credit(s)TM
In this activity, expert faculty give their multidisciplinary perspectives in vascular surgery and cardiology regarding recommendations for patients with peripheral artery disease (PAD) post-revascularization. These patients are at risk for further complications and may be eligible for additional therapy. Dr. Marc Bonaca and Dr. Alan Dietzek relay practice implications of the latest guidelines and data across the various agents and combinations for patients with PAD.
Clinical Implications of Echo-Derived Hemodynamic Findings After TAVR

Clinical Implications of Echo-Derived Hemodynamic Findings After TAVR | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), Category A CE Credit(s), AAPA Category I CME credit
As the population of patients who have undergone transcatheter aortic valve replacement (TAVR) grows, healthcare providers are increasingly challenged to provide these patients with appropriate monitoring, particularly in relation to the potential for structural valve deterioration.
TAVR: Optimizing Resource Utilization in the Management of Patients With Aortic Stenosis

TAVR: Optimizing Resource Utilization in the Management of Patients With Aortic Stenosis | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
Severe symptomatic aortic stenosis demands urgent care—but which approach is best? In this video webinar, 3 experts explore the clinical pathways and health economics of transcatheter aortic valve replacement (TAVR) in comparison to traditional open surgical valve replacement (SAVR), including the impact of treatment delays in this vulnerable population.
TAVR Today: Real-World Challenges; Real-World Opportunities—An Expert Perspective Roundtable on New and Emerging Data on TAVR

TAVR Today: Real-World Challenges; Real-World Opportunities | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Transcatheter aortic valve replacement (TAVR) has revolutionized the care of aortic valve stenosis, facilitating intervention in patients who are poor candidates for surgical aortic valve replacement (SAVR) and demonstrating benefit in those at low surgical risk. This roundtable features a leading cardiac surgeon and a noted interventional cardiologist with a prominent clinical cardiologist reviewing the lastest data about TAVR and SAVR as well as when to recommend each procedure.
Chest Drainage as a Therapeutic Intervention: Getting Back to Basics

Chest Drainage as a Therapeutic Intervention | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
To meet the educational needs of clinicians involved in the management of patients receiving a chest drainage procedure, this activity will provide an in-depth review of the normal anatomy and the thorax and the physiology or respiration as well as a description of the pathologies that may warrant the need for pleural space drainage. Traditional and new-generation chest drainage systems will be compared and trouble-shooting tips will be presented.

Click for More Cardiology Courses

Next hm-section-front in CME